Brief: Theravance Biopharma, Inc. Reports First Quarter 2022 Financial Results
05/05/2022 23:56
May 5 (Reuters) - Theravance Biopharma Inc TBPH.O :
* THERAVANCE BIOPHARMA, INC. REPORTS FIRST QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* THERAVANCE BIOPHARMA INC - CASH, CASH EQUIVALENTS AND
MARKETABLE
SECURITIES TOTALED $147.5 MILLION AS OF MARCH 31, 2022
* THERAVANCE BIOPHARMA INC - EXPECTS TO BE SUSTAINABLY
CASH-FLOW
POSITIVE BEGINNING 2H 2022 AND GOING FORWARD ON AN ANNUAL BASIS
Source text for Eikon: ID:nPn28d73ha
Further company coverage: TBPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theravance Biopharma
See all newsIreland's Theravance Biopharma Q1 revenue beats estimates on YUPELRI growth
Ireland's Theravance Biopharma Q4 revenue misses expectations
Corrected: BRIEF-Theravance Biopharma Q4 Operating Income USD 20.012 Million
U.S. STOCKS ON THE MOVE-Versant Media Group, Lithium miners, Expedia Group
U.S. STOCKS ON THE MOVE-Expedia Group, Blue Owl Capital, Enphase Energy